KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

AbbVie (ABBV) Short-Term Debt issuances (2016 - 2026)

AbbVie has reported Short-Term Debt issuances over the past 9 years, most recently at -$4.3 billion for Q4 2025.

Quarterly Short-Term Debt issuances changed N/A to -$4.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $499.0 million through Dec 2025, down 94.07% year-over-year, with the annual reading at $499.0 million for FY2025, 90.04% down from the prior year.
Short-Term Debt issuances was -$4.3 billion for Q4 2025 at AbbVie, down from $3.2 billion in the prior quarter.
Over five years, Short-Term Debt issuances peaked at $5.0 billion in Q1 2024 and troughed at -$4.3 billion in Q4 2025.